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Supporting Text

Supporting Text A. Conversion of mean difference to odds ratios
As demonstrated by Perry et al [1] , an effect estimate such as the standardised mean difference (SMD) can be converted to an odds ratio using the following formula:
In support of this, Borenstein et al [2] stated that the SMD can be converted to the log odds ratio with the following formula:
= √
The method assumes continuous data to have a logistic distribution rather a normal distribution. As analyses of continuous outcomes are commonly performed assuming a normal distribution, the variance (V) of the log odds ratio is as follows:
=
The variance of the standard logistic distribution is π 2 /3, therefore the SMD can be converted to ln(odds) by multiplying by π/√3 or 1.81 to 2 decimal places [3] .
This method was applied in the current study to obtain odds ratios for the association between BMI and psoriasis found during the meta-analysis of previously reported observational studies. In applying the first formula, SD denotes the standard deviation change in BMI per standard deviation change in the BMI genetic instrument. In individuals from the UK Biobank, we found this to be 0.135, using the BMI genetic risk score as the genetic instrument. SMD denotes the standardised mean difference in BMI estimated from the association studies that were meta-analysed. In adults this was found to be 0.360 (95% CI = 0.206, 0.515), and 0.363 in children (95% CI = 0.262, 0.465).
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Supporting Text B. Reverse direction MR analysis: genetic liability as a linear variable
An additional one-sample MR analysis was performed where the genetic liability of psoriasis was considered as a linear variable with values from "0" to "1". This was performed in the UK Biobank and HUNT datasets using the two-staged least squares (TSLS) method with the "ivpack" R package [1] using individual SNPs for psoriasis as an instrument. This analysis involves two linear regression stages where psoriasis is first regressed upon the instrument (disease-associated SNPs), then the outcome (BMI) is regressed upon the fitted values from the first stage regression. The estimates from each genetic instrument were meta-analysed assuming a random effects model to give a single estimate for the effect of psoriasis genetic risk upon BMI within UK Biobank and HUNT. The estimates from each dataset were then meta-analysed assuming a fixed effect model to give an overall causal effect. ) and potential confounders in UK Biobank. Estimates are given per 1 copy increase in effect allele (A). A-level, Advanced level studies; CI, confidence interval; GCSE, General Certificate of Secondary Education; Monthly Alcohol Consumption, defined as frequency of "one to three times a month". Results from MR analysis using rs1558902 as an instrumental variable. These are compared with final estimates obtained when using all BMI SNPs as a genetic instrument. One-sample MR was performed with individual-level data from UK Biobank and HUNT. Two-sample MR was performed with published GWAS summary-level data for BMI and psoriasis. Estimates are given per 1 unit increase in BMI (kg/m 2 ).
Fig I. Association of psoriasis SNPs with psoriasis and BMI within (a) UK Biobank and (b) HUNT.
IVW, MR-Egger, weighted median and simple median estimates are indicated by the red, green, purple and blue lines respectively. 
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